GlassScriptPhysician profile
Christopher Carnabatu
NPI 1225532591
$5,478.07
in general payments reported to CMS, 2019-2025
11 companies · $2,103 in 2025
The $2,103 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $77.71 · 2023: $13.64 · 2024: $3,283 · 2025: $2,103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,767 · Food and Beverage: $2,286 · Education: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,766.56 |
| Food and Beverage | $2,286.15 |
| Education | $347.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,567.42 | 2024-2025 | Pteye Parathyroid Detection System, Signia |
| Enterra Medical, INC. | $969.37 | 2025 | |
| Stryker Corporation | $785.68 | 2024 | 1788 |
| Baxter Healthcare | $397.17 | 2024-2025 | Perclot, Seprafilm, Floseal |
| Teleflex LLC | $271.73 | 2025 | Titan Sgs Bailout Chuck |
| W. L. Gore & Associates, INC. | $268.16 | 2024-2025 | Gore Enform Preperitoneal Biomaterial, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Davol INC. | $91.78 | 2024 | Arista Ah Flexitip |
| Silk Road Medical, INC. | $77.71 | 2021 | |
| Acera Surgical, INC. | $19.62 | 2025 | Restrata Wound Matrix |
| Shield Therapeutics INC | $15.79 | 2025 | |
| Merck Sharp & Dohme LLC | $13.64 | 2023 | Dificid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Carnabatu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.